Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245

Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel circular RNAs. This study aimed at investigating the biological functions and molecular mechanisms of hsa_circ_0046264 in lung cancer which may be helpfu...

Full description

Saved in:
Bibliographic Details
Published inRespiratory research Vol. 19; no. 1; p. 115
Main Authors Yang, Liu, Wang, Jun, Fan, Yaodong, Yu, Kun, Jiao, Baowei, Su, Xiaosan
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 11.06.2018
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel circular RNAs. This study aimed at investigating the biological functions and molecular mechanisms of hsa_circ_0046264 in lung cancer which may be helpful in lung cancer early diagnosis and clinical treatment. Gene microarray data screened the differential gene of hsa_circ_0046264 and its downstream genes were found by bioinformatics analysis and verified by luciferase reporter assay. QRT-PCR and Western blot was used to detect the RNA and protein levels respectively. RNase R digestion confirmed the existences of circular RNA. Cell viability, invasion and apoptosis were determined by MTT assay, flow cytometry and DNA damage assay. Tumor formation in nude mice and immunohistochemistry proved the functions of hsa_circ_0046264 in vivo. Hsa_circ_0046264 and BRCA2 were down-regulated in lung cancer tissues while miR-1245 was up-regulated. Hsa_circ_0046264 induced apoptosis but inhibited proliferation and invasion of lung cancer cells through targeting miR-1245 to up-regulate BRCA2. Hsa_circ_0046264 inhibited the tumor growth in vivo. Hsa_circ_0046264 was a tumor suppressor in lung cancer. Overexpression of hsa_circ_0046264 could up-regulate BRCA2 expression through down-regulating of miR-1245.
AbstractList OBJECTIVELung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel circular RNAs. This study aimed at investigating the biological functions and molecular mechanisms of hsa_circ_0046264 in lung cancer which may be helpful in lung cancer early diagnosis and clinical treatment.METHODSGene microarray data screened the differential gene of hsa_circ_0046264 and its downstream genes were found by bioinformatics analysis and verified by luciferase reporter assay. QRT-PCR and Western blot was used to detect the RNA and protein levels respectively. RNase R digestion confirmed the existences of circular RNA. Cell viability, invasion and apoptosis were determined by MTT assay, flow cytometry and DNA damage assay. Tumor formation in nude mice and immunohistochemistry proved the functions of hsa_circ_0046264 in vivo.RESULTSHsa_circ_0046264 and BRCA2 were down-regulated in lung cancer tissues while miR-1245 was up-regulated. Hsa_circ_0046264 induced apoptosis but inhibited proliferation and invasion of lung cancer cells through targeting miR-1245 to up-regulate BRCA2. Hsa_circ_0046264 inhibited the tumor growth in vivo.CONCLUSIONHsa_circ_0046264 was a tumor suppressor in lung cancer. Overexpression of hsa_circ_0046264 could up-regulate BRCA2 expression through down-regulating of miR-1245.
Abstract Objective Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel circular RNAs. This study aimed at investigating the biological functions and molecular mechanisms of hsa_circ_0046264 in lung cancer which may be helpful in lung cancer early diagnosis and clinical treatment. Methods Gene microarray data screened the differential gene of hsa_circ_0046264 and its downstream genes were found by bioinformatics analysis and verified by luciferase reporter assay. QRT-PCR and Western blot was used to detect the RNA and protein levels respectively. RNase R digestion confirmed the existences of circular RNA. Cell viability, invasion and apoptosis were determined by MTT assay, flow cytometry and DNA damage assay. Tumor formation in nude mice and immunohistochemistry proved the functions of hsa_circ_0046264 in vivo. Results Hsa_circ_0046264 and BRCA2 were down-regulated in lung cancer tissues while miR-1245 was up-regulated. Hsa_circ_0046264 induced apoptosis but inhibited proliferation and invasion of lung cancer cells through targeting miR-1245 to up-regulate BRCA2. Hsa_circ_0046264 inhibited the tumor growth in vivo. Conclusion Hsa_circ_0046264 was a tumor suppressor in lung cancer. Overexpression of hsa_circ_0046264 could up-regulate BRCA2 expression through down-regulating of miR-1245.
Objective Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel circular RNAs. This study aimed at investigating the biological functions and molecular mechanisms of hsa_circ_0046264 in lung cancer which may be helpful in lung cancer early diagnosis and clinical treatment. Methods Gene microarray data screened the differential gene of hsa_circ_0046264 and its downstream genes were found by bioinformatics analysis and verified by luciferase reporter assay. QRT-PCR and Western blot was used to detect the RNA and protein levels respectively. RNase R digestion confirmed the existences of circular RNA. Cell viability, invasion and apoptosis were determined by MTT assay, flow cytometry and DNA damage assay. Tumor formation in nude mice and immunohistochemistry proved the functions of hsa_circ_0046264 in vivo. Results Hsa_circ_0046264 and BRCA2 were down-regulated in lung cancer tissues while miR-1245 was up-regulated. Hsa_circ_0046264 induced apoptosis but inhibited proliferation and invasion of lung cancer cells through targeting miR-1245 to up-regulate BRCA2. Hsa_circ_0046264 inhibited the tumor growth in vivo. Conclusion Hsa_circ_0046264 was a tumor suppressor in lung cancer. Overexpression of hsa_circ_0046264 could up-regulate BRCA2 expression through down-regulating of miR-1245. Keywords: hsa_circ_0046264, Hsa-miR-1245, BRCA2, Lung cancer
Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel circular RNAs. This study aimed at investigating the biological functions and molecular mechanisms of hsa_circ_0046264 in lung cancer which may be helpful in lung cancer early diagnosis and clinical treatment. Gene microarray data screened the differential gene of hsa_circ_0046264 and its downstream genes were found by bioinformatics analysis and verified by luciferase reporter assay. QRT-PCR and Western blot was used to detect the RNA and protein levels respectively. RNase R digestion confirmed the existences of circular RNA. Cell viability, invasion and apoptosis were determined by MTT assay, flow cytometry and DNA damage assay. Tumor formation in nude mice and immunohistochemistry proved the functions of hsa_circ_0046264 in vivo. Hsa_circ_0046264 and BRCA2 were down-regulated in lung cancer tissues while miR-1245 was up-regulated. Hsa_circ_0046264 induced apoptosis but inhibited proliferation and invasion of lung cancer cells through targeting miR-1245 to up-regulate BRCA2. Hsa_circ_0046264 inhibited the tumor growth in vivo. Hsa_circ_0046264 was a tumor suppressor in lung cancer. Overexpression of hsa_circ_0046264 could up-regulate BRCA2 expression through down-regulating of miR-1245.
Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel circular RNAs. This study aimed at investigating the biological functions and molecular mechanisms of hsa_circ_0046264 in lung cancer which may be helpful in lung cancer early diagnosis and clinical treatment. Gene microarray data screened the differential gene of hsa_circ_0046264 and its downstream genes were found by bioinformatics analysis and verified by luciferase reporter assay. QRT-PCR and Western blot was used to detect the RNA and protein levels respectively. RNase R digestion confirmed the existences of circular RNA. Cell viability, invasion and apoptosis were determined by MTT assay, flow cytometry and DNA damage assay. Tumor formation in nude mice and immunohistochemistry proved the functions of hsa_circ_0046264 in vivo. Hsa_circ_0046264 and BRCA2 were down-regulated in lung cancer tissues while miR-1245 was up-regulated. Hsa_circ_0046264 induced apoptosis but inhibited proliferation and invasion of lung cancer cells through targeting miR-1245 to up-regulate BRCA2. Hsa_circ_0046264 inhibited the tumor growth in vivo. Hsa_circ_0046264 was a tumor suppressor in lung cancer. Overexpression of hsa_circ_0046264 could up-regulate BRCA2 expression through down-regulating of miR-1245.
Objective Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel circular RNAs. This study aimed at investigating the biological functions and molecular mechanisms of hsa_circ_0046264 in lung cancer which may be helpful in lung cancer early diagnosis and clinical treatment. Methods Gene microarray data screened the differential gene of hsa_circ_0046264 and its downstream genes were found by bioinformatics analysis and verified by luciferase reporter assay. QRT-PCR and Western blot was used to detect the RNA and protein levels respectively. RNase R digestion confirmed the existences of circular RNA. Cell viability, invasion and apoptosis were determined by MTT assay, flow cytometry and DNA damage assay. Tumor formation in nude mice and immunohistochemistry proved the functions of hsa_circ_0046264 in vivo. Results Hsa_circ_0046264 and BRCA2 were down-regulated in lung cancer tissues while miR-1245 was up-regulated. Hsa_circ_0046264 induced apoptosis but inhibited proliferation and invasion of lung cancer cells through targeting miR-1245 to up-regulate BRCA2. Hsa_circ_0046264 inhibited the tumor growth in vivo. Conclusion Hsa_circ_0046264 was a tumor suppressor in lung cancer. Overexpression of hsa_circ_0046264 could up-regulate BRCA2 expression through down-regulating of miR-1245.
ArticleNumber 115
Audience Academic
Author Su, Xiaosan
Jiao, Baowei
Yu, Kun
Fan, Yaodong
Yang, Liu
Wang, Jun
Author_xml – sequence: 1
  givenname: Liu
  surname: Yang
  fullname: Yang, Liu
  organization: Biomedical Research Center, the Affiliated Calmette Hospital of Kunming Medical University (the First Hospital of Kunming), No. 504 Qingnian Road, Kunming, 650011, Yunnan, China
– sequence: 2
  givenname: Jun
  surname: Wang
  fullname: Wang, Jun
  organization: Department of Anesthesiology, the First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China
– sequence: 3
  givenname: Yaodong
  surname: Fan
  fullname: Fan, Yaodong
  organization: Department of Neurosurgery, the Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, 650118, Yunnan, China
– sequence: 4
  givenname: Kun
  surname: Yu
  fullname: Yu, Kun
  organization: Department of Colorectal Cancer, the Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, 650118, Yunnan, China
– sequence: 5
  givenname: Baowei
  surname: Jiao
  fullname: Jiao, Baowei
  organization: State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, Yunnan, China
– sequence: 6
  givenname: Xiaosan
  surname: Su
  fullname: Su, Xiaosan
  email: suxs163@163.com
  organization: Biomedical Research Center, the Affiliated Calmette Hospital of Kunming Medical University (the First Hospital of Kunming), No. 504 Qingnian Road, Kunming, 650011, Yunnan, China. suxs163@163.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29891014$$D View this record in MEDLINE/PubMed
BookMark eNptkl2L1DAUhousuB_6A7yRgjfedM13kxthHNRdWBAWBfEmnKannQydZkxawX9v6qzDjkggCSfvec454b0szsYwYlG8pOSaUq3eJsoMpxWhuiKamqp-UlxQoWRlDP929uh-XlymtCWE1rqWz4pzZrShhIqL4vtNAut8dJYQoZgS5byvIvbzABO25fv79YqVUyjTvN9HTKkc5rEvHYwOYzltYpj7TTlB7HHy-WGToNr5-4oyIZ8XTzsYEr54OK-Krx8_fFnfVHefP92uV3eVk4pMlUYNuU8CvBaU1I5g3TVNrVtGnahrNADYuY5Dh1pyIQAc18AAtJa6aSi_Km4P3DbA1u6j30H8ZQN4-ycQYm8hTt4NaAUD15BOdoYRAQQbIrVsch8qwzhrMuvdgbWfmx22DscpwnACPX0Z_cb24aeVxiihSQa8eQDE8GPGNNmdTw6HAUYMc7KMSGGolqbO0tf_SLdhjmP-qkWlFNcqb0dVD3kAP3Yh13UL1K6kUNoIxZey1_9R5dXizrvsms7n-EkCPSS4GFKK2B1npMQu5rIHc9lsLruYyy4Nv3r8OceMv27ivwEQMMkU
CitedBy_id crossref_primary_10_1080_21655979_2021_1965697
crossref_primary_10_1002_jcp_28481
crossref_primary_10_1016_j_omtn_2021_05_018
crossref_primary_10_1007_s00432_019_03045_4
crossref_primary_10_1016_j_biocel_2020_105702
crossref_primary_10_1186_s12935_020_01360_2
crossref_primary_10_1155_2021_9978206
crossref_primary_10_1016_j_ygeno_2020_12_013
crossref_primary_10_1186_s12958_021_00795_0
crossref_primary_10_3389_fonc_2021_664290
crossref_primary_10_1016_j_biocel_2024_106548
crossref_primary_10_3892_ijmm_2020_4549
crossref_primary_10_1002_cnr2_1955
crossref_primary_10_1089_cbr_2020_4217
crossref_primary_10_1080_21655979_2022_2031400
crossref_primary_10_1007_s10529_021_03081_6
crossref_primary_10_1097_MD_0000000000025415
crossref_primary_10_3389_fonc_2020_00026
crossref_primary_10_1136_postgradmedj_2019_137178
crossref_primary_10_3390_cancers13040733
crossref_primary_10_1186_s13018_021_02782_y
crossref_primary_10_1186_s12929_024_01049_y
crossref_primary_10_1016_j_dnarep_2020_103036
crossref_primary_10_1186_s12957_018_1515_2
crossref_primary_10_1515_biol_2021_0009
crossref_primary_10_1155_2019_8023541
crossref_primary_10_1155_2022_3676685
crossref_primary_10_1620_tjem_254_189
crossref_primary_10_3389_fonc_2022_862602
crossref_primary_10_3390_biomedicines9111642
crossref_primary_10_1038_s41417_022_00489_8
crossref_primary_10_1002_jcla_24347
crossref_primary_10_3390_ijms24033050
crossref_primary_10_1155_2020_5103272
crossref_primary_10_3389_fgene_2021_632359
Cites_doi 10.18632/oncotarget.13656
10.1007/s40265-017-0732-2
10.1038/oncsis.2013.45
10.18632/oncotarget.16881
10.1111/febs.14132
10.1038/srep30919
10.1186/s12929-016-0240-9
10.1136/jmedgenet-2015-103672
10.3324/haematol.2011.058529
10.1016/j.bbrc.2017.09.136
10.1002/anie.201710398
10.1158/0008-5472.CAN-13-1568
10.18632/oncotarget.20441
10.3233/CBM-170379
10.1159/000485953
10.1016/j.biopha.2017.12.015
10.1158/1078-0432.CCR-05-2694
10.1093/jmcb/mjr046
10.4161/21541272.2014.944014
10.3322/caac.21387
10.1038/nature11993
10.1016/j.humpath.2017.04.007
10.1007/s10549-016-3902-0
10.1002/cam4.748
10.5301/tj.5000473
10.1038/nrg2843
10.1007/s13277-015-3093-z
10.1016/j.canlet.2017.06.027
ContentType Journal Article
Copyright COPYRIGHT 2018 BioMed Central Ltd.
Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2018
Copyright_xml – notice: COPYRIGHT 2018 BioMed Central Ltd.
– notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2018
DBID NPM
AAYXX
CITATION
3V.
7QL
7U7
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PIMPY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12931-018-0819-7
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Toxicology Abstracts
Virology and AIDS Abstracts
Health & Medical Complete (ProQuest Database)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
Toxicology Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



PubMed
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1465-993X
1465-9921
EndPage 115
ExternalDocumentID oai_doaj_org_article_42acb0f5f9204a0eb0585bc56688532b
A546894630
10_1186_s12931_018_0819_7
29891014
Genre Journal Article
GeographicLocations United States--US
China
GeographicLocations_xml – name: China
– name: United States--US
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 31360223
– fundername: National Natural Science Foundation of China
  grantid: 81760519
– fundername: ;
  grantid: 81760519; 31360223
GroupedDBID ---
-A0
0R~
29P
2WC
3V.
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
AFPKN
CITATION
ABVAZ
AFGXO
AFNRJ
7QL
7U7
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c560t-8e8a4650a374107c0e7fbb78d21c477e9aaefcf3afe85344aac38a2aa8858bb13
IEDL.DBID RPM
ISSN 1465-993X
1465-9921
IngestDate Tue Oct 22 15:10:45 EDT 2024
Tue Sep 17 20:47:20 EDT 2024
Fri Oct 25 05:42:08 EDT 2024
Sat Nov 09 11:10:54 EST 2024
Thu Feb 22 23:42:21 EST 2024
Tue Nov 12 22:45:54 EST 2024
Thu Sep 12 18:14:04 EDT 2024
Wed Oct 16 00:59:33 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Hsa-miR-1245
BRCA2
Lung cancer
hsa_circ_0046264
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-8e8a4650a374107c0e7fbb78d21c477e9aaefcf3afe85344aac38a2aa8858bb13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996480/
PMID 29891014
PQID 2056638666
PQPubID 42864
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_42acb0f5f9204a0eb0585bc56688532b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5996480
proquest_miscellaneous_2054918597
proquest_journals_2056638666
gale_infotracmisc_A546894630
gale_infotracacademiconefile_A546894630
crossref_primary_10_1186_s12931_018_0819_7
pubmed_primary_29891014
PublicationCentury 2000
PublicationDate 2018-06-11
PublicationDateYYYYMMDD 2018-06-11
PublicationDate_xml – month: 06
  year: 2018
  text: 2018-06-11
  day: 11
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Respiratory research
PublicationTitleAlternate Respir Res
PublicationYear 2018
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 28687357 - Cancer Lett. 2017 Sep 10;403:305-317
27642589 - Biomed Res Int. 2016;2016:1579490
25483404 - Transcription. 2014;5(4):e944014
28685964 - FEBS J. 2017 Jul;284(14 ):2170-2182
29241190 - Cell Physiol Biochem. 2017;44(6):2138-2146
29207057 - Int J Oncol. 2018 Feb;52(2):321-336
28378229 - Drugs. 2017 May;77(8):813-827
24014594 - Cancer Res. 2013 Sep 15;73(18):5609-12
25973291 - Am J Cancer Res. 2015 Jan 15;5(2):472-80
27393621 - Breast Cancer Res Treat. 2016 Aug;158(3):455-62
29103021 - Cancer Biomark. 2018 Feb 6;21(2):299-306
28438622 - Hum Pathol. 2017 Oct;68:22-25
27903978 - Oncotarget. 2017 Jan 3;8(1):808-818
27167707 - Cancer Med. 2016 Jul;5(7):1640-6
28958934 - Biochem Biophys Res Commun. 2017 Nov 25;493(3):1260-1266
20661255 - Nat Rev Genet. 2010 Sep;11(9):597-610
29223555 - Biomed Pharmacother. 2017 Dec;96:892-898
29178586 - Angew Chem Int Ed Engl. 2018 Feb 23;57(9):2307-2313
28938566 - Oncotarget. 2017 Apr 6;8(35):58405-58416
29207642 - Oncotarget. 2017 Aug 24;8(53):91270-91280
28055103 - CA Cancer J Clin. 2017 Jan;67(1):7-30
22491735 - Haematologica. 2012 Sep;97(9):1295-303
27484176 - Sci Rep. 2016 Aug 03;6:30919
26979245 - Tumori. 2016 Mar-Apr;102(2):150-5
17289874 - Clin Cancer Res. 2007 Feb 1;13(3):832-8
23446346 - Nature. 2013 Mar 21;495(7441):384-8
22158906 - J Mol Cell Biol. 2012 Apr;4(2):108-17
26842001 - J Biomed Sci. 2016 Feb 03;23 :23
24336406 - Oncogenesis. 2013 Dec 16;2:e82
25604144 - Tumour Biol. 2015 Feb;36(2):479-88
26928436 - J Med Genet. 2016 Jul;53(7):465-71
AA Arbini (819_CR13) 2013; 2
J Li (819_CR6) 2015; 5
L Fu (819_CR24) 2017; 8
L Wan (819_CR9) 2016; 2016
J Lategahn (819_CR2) 2018; 57
RL Siegel (819_CR1) 2017; 67
X Zhu (819_CR11) 2017; 284
YH Luo (819_CR27) 2017; 96
BK Dey (819_CR20) 2014; 5
MN Lee (819_CR18) 2007; 13
JL Espinoza (819_CR14) 2012; 97
M Koczkowska (819_CR17) 2016; 5
L Song (819_CR15) 2012; 4
Z Zhong (819_CR23) 2016; 6
TB Hansen (819_CR8) 2013; 73
F Tian (819_CR10) 2017; 493
L Peng (819_CR19) 2017; 8
J Zhao (819_CR26) 2017; 44
DL Cheng (819_CR21) 2015; 36
K Kast (819_CR29) 2016; 53
TB Hansen (819_CR7) 2013; 495
J Zhang (819_CR28) 2016; 158
X Wang (819_CR16) 2017; 68
Y Lin (819_CR31) 2016; 102
J Krol (819_CR12) 2010; 11
B Rong (819_CR4) 2018; 52
Z Zhong (819_CR22) 2017; 403
H Sun (819_CR25) 2018; 21
SY Yang (819_CR30) 2016; 23
SO Dolly (819_CR3) 2017; 77
X Jin (819_CR5) 2017; 8
References_xml – volume: 8
  start-page: 808
  year: 2017
  ident: 819_CR19
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.13656
  contributor:
    fullname: L Peng
– volume: 77
  start-page: 813
  year: 2017
  ident: 819_CR3
  publication-title: Drugs
  doi: 10.1007/s40265-017-0732-2
  contributor:
    fullname: SO Dolly
– volume: 2016
  start-page: 1579490
  year: 2016
  ident: 819_CR9
  publication-title: Biomed Res Int
  contributor:
    fullname: L Wan
– volume: 5
  start-page: 472
  year: 2015
  ident: 819_CR6
  publication-title: Am J Cancer Res
  contributor:
    fullname: J Li
– volume: 2
  start-page: e82
  year: 2013
  ident: 819_CR13
  publication-title: Oncogenesis
  doi: 10.1038/oncsis.2013.45
  contributor:
    fullname: AA Arbini
– volume: 8
  start-page: 58405
  year: 2017
  ident: 819_CR24
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.16881
  contributor:
    fullname: L Fu
– volume: 284
  start-page: 2170
  year: 2017
  ident: 819_CR11
  publication-title: FEBS J
  doi: 10.1111/febs.14132
  contributor:
    fullname: X Zhu
– volume: 6
  start-page: 30919
  year: 2016
  ident: 819_CR23
  publication-title: Sci Rep
  doi: 10.1038/srep30919
  contributor:
    fullname: Z Zhong
– volume: 23
  start-page: 23
  year: 2016
  ident: 819_CR30
  publication-title: J Biomed Sci
  doi: 10.1186/s12929-016-0240-9
  contributor:
    fullname: SY Yang
– volume: 53
  start-page: 465
  year: 2016
  ident: 819_CR29
  publication-title: J Med Genet
  doi: 10.1136/jmedgenet-2015-103672
  contributor:
    fullname: K Kast
– volume: 97
  start-page: 1295
  year: 2012
  ident: 819_CR14
  publication-title: Haematologica
  doi: 10.3324/haematol.2011.058529
  contributor:
    fullname: JL Espinoza
– volume: 493
  start-page: 1260
  year: 2017
  ident: 819_CR10
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2017.09.136
  contributor:
    fullname: F Tian
– volume: 57
  start-page: 2307
  year: 2018
  ident: 819_CR2
  publication-title: Angew Chem Int Ed Engl
  doi: 10.1002/anie.201710398
  contributor:
    fullname: J Lategahn
– volume: 73
  start-page: 5609
  year: 2013
  ident: 819_CR8
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-13-1568
  contributor:
    fullname: TB Hansen
– volume: 8
  start-page: 91270
  year: 2017
  ident: 819_CR5
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.20441
  contributor:
    fullname: X Jin
– volume: 21
  start-page: 299
  year: 2018
  ident: 819_CR25
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-170379
  contributor:
    fullname: H Sun
– volume: 44
  start-page: 2138
  year: 2017
  ident: 819_CR26
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000485953
  contributor:
    fullname: J Zhao
– volume: 96
  start-page: 892
  year: 2017
  ident: 819_CR27
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2017.12.015
  contributor:
    fullname: YH Luo
– volume: 13
  start-page: 832
  year: 2007
  ident: 819_CR18
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-05-2694
  contributor:
    fullname: MN Lee
– volume: 4
  start-page: 108
  year: 2012
  ident: 819_CR15
  publication-title: J Mol Cell Biol
  doi: 10.1093/jmcb/mjr046
  contributor:
    fullname: L Song
– volume: 5
  start-page: e944014
  year: 2014
  ident: 819_CR20
  publication-title: Transcription
  doi: 10.4161/21541272.2014.944014
  contributor:
    fullname: BK Dey
– volume: 67
  start-page: 7
  year: 2017
  ident: 819_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21387
  contributor:
    fullname: RL Siegel
– volume: 52
  start-page: 321
  year: 2018
  ident: 819_CR4
  publication-title: Int J Oncol
  contributor:
    fullname: B Rong
– volume: 495
  start-page: 384
  year: 2013
  ident: 819_CR7
  publication-title: Nature
  doi: 10.1038/nature11993
  contributor:
    fullname: TB Hansen
– volume: 68
  start-page: 22
  year: 2017
  ident: 819_CR16
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2017.04.007
  contributor:
    fullname: X Wang
– volume: 158
  start-page: 455
  year: 2016
  ident: 819_CR28
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-016-3902-0
  contributor:
    fullname: J Zhang
– volume: 5
  start-page: 1640
  year: 2016
  ident: 819_CR17
  publication-title: Cancer Med
  doi: 10.1002/cam4.748
  contributor:
    fullname: M Koczkowska
– volume: 102
  start-page: 150
  year: 2016
  ident: 819_CR31
  publication-title: Tumori
  doi: 10.5301/tj.5000473
  contributor:
    fullname: Y Lin
– volume: 11
  start-page: 597
  year: 2010
  ident: 819_CR12
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg2843
  contributor:
    fullname: J Krol
– volume: 36
  start-page: 479
  year: 2015
  ident: 819_CR21
  publication-title: Tumour Biol
  doi: 10.1007/s13277-015-3093-z
  contributor:
    fullname: DL Cheng
– volume: 403
  start-page: 305
  year: 2017
  ident: 819_CR22
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2017.06.027
  contributor:
    fullname: Z Zhong
SSID ssj0017875
Score 2.445085
Snippet Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel circular...
Objective Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel...
OBJECTIVELung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify novel...
Abstract Objective Lung cancer had been leading mounts of deaths worldwide. Advances in genes microarray had helped human further understand genes and identify...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 115
SubjectTerms Apoptosis
Assaying
Bioinformatics
BRCA2
BRCA2 protein
Breast cancer
Cancer
Cancer therapies
Cell proliferation
Chemotherapy
Circular RNA
Deoxyribonucleic acid
Diagnosis
DNA
DNA damage
DNA microarrays
Flow cytometry
Gene expression
Genes
Genetic aspects
Hsa-miR-1245
hsa_circ_0046264
Immunohistochemistry
Lung cancer
Metastasis
MicroRNA
Molecular chains
Molecular modelling
Mutation
Ovarian cancer
Patient outcomes
Proteins
Ribonuclease
Ribonucleic acid
RNA
Tumor suppressor genes
Tumors
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9BLadOX07QoECgURGRb1uO4CQ1LIDmEBkIvYiTLZKH1Luvd_9-RrF3W9NBLr5YM0jczmhk0-oaQCwEagukapmrQTPiGM2gCMHDKNHXr0efFG927ezl_FLdPzdNBq69YEzbSA4_AXYoKvONd05mKC-DBcQxwnccoRKOnqVw6fbnZJVP5_gDVsMl3mKWWl0P0ajFtjmzMpWFq4oUSWf_fR_KBT5rWSx44oJvX5FWOHOlsXPEb8iL0J-T4Lt-NvyU_5wNYv1h7m56CSkG3K7YeW82Hll49XM8qulnSYbtKxa_0F9o59VHqa5rb9dCxMBzdGX0egP1ePDD0zM078njz_cf1nOXOCQyB4RumgwaBsRfUGDBw5XlQnXNKt1XphVLBAITOdzV0AUEUAsDXGioAxFQ7V9bvyVG_7MNHQg2aqQtBOMmFUK3W8e2rFFL6uqxVaAvybYekXY0EGTYlFlraEXaLsNsIu1UFuYpY7ydGbuv0ASVus8TtvyRekK9RUjZaIIrDQ35IgOuNXFZ21gipjZA1L8jZZCZajp8O72Rts-UOtsKIEM8kzOoKcr4fjn_GarQ-LLdpjjAY6Bjc0IdRNfZbioz2sf9xQdREaSZ7no70i-fE6x2ZcoTmp_8DpE_kZZXUXbKyPCNHm_U2fMbwaeO-JEv5A1bgFBw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Complete (ProQuest Database)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgiftvzlAiCIATT5rNPsnd4LML5cHiw-BImaeotnN11u_v_36TNrlcEX5sUMpOZ_GaS-SDkgwQLsW4VMwIsk0FxBioCA29qJZqAmJdedC--6_mV_LZQi3zh1uewyv2ZOBzUzSqkO3J00tHwEBat7S_rPyx1jUqvq7mFxn3yoKy4TiFdZnFwuEoURjVmFymGOLzIr5ql1Z_7hHPJkU71mcuamQkuDeX7_z2k76DUNILyDiSdPyGPsy1JZ-PmPyX3YveMPLzIr-XPyc95Dy4sN8ENyaFa0t2abcbm87Ghp5dns4puV7TfrYdwWHqDmk9DkoMNzQ186BgqjgBHr3tgv5eXDLFavSBX519_nM1Z7qXAAto0W2ajBWQDB4EmBDeBR9N6b2xTlUEaE2uA2IZWQBsRwKUECMJCBWCtst6X4iU56lZdfE1ojYrrY5RecylNY23KhtVS6yBKYWJTkE97Trr1WDLDDa6G1W5ku0O2u8R2Zwpymnh9mJiqXQ8fVptfLiuPkxUEz1vV1hWXwKPn6OR4JEzj6kTlC_Ix7ZRLOonbESCnFuB6U3UrN1NS21pqwQtyMpmJuhSmw_u9dlmXe_dX8gry_jCc_kzxaV1c7YY5skbTp0aCXo2icSAp1bhPHZELYiZCM6F5OtItr4dK36l2jrT8-P_LekMeVYMga1aWJ-Rou9nFt2gqbf27QR9uAdtaDgk
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA-1gvgifru1SgRBEKK7m899ELkWyyHUh-JB8SVMctn2oO6du3dQ_3sn2b2zi330dZPAzld-M8xkhpC3AgyEqpZMczBMeJkzkAEYOF1JPveIeTGje_pNTWfi67k83yPb8VYDA7tbQ7s4T2rWXn24_vX7Mxr8p2TwRn3sImbFoDj2Wi4qpu-Qu6XAQD1W8om_SQXUTTkkNm89NoKm1MH_33v6BlCNiyhvoNLJQ_JgcCfppJf_I7IXmsfk3umQMH9Cfkw7sH7RepvehypBNyvW9vPnw5wenR1PSrpe0m6zShWx9AqNn_qoCi0dZvjQvlocMY5edsB-Ls4YwrV8SmYnX74fT9kwToF5dGvWzAQDAh0y4OhF5NrnQdfOaTMvCy-0DhVAqH3NoQ6I4UIAeG6gBDBGGucK_ozsN8smvCC0Qtt1IQinciH03Jj4IFYJpTwvuA7zjLzfctKu-q4ZNkUbRtme7RbZbiPbrc7IUeT1bmNseJ0-LNsLO9iPFSV4l9eyrspcQB5cjnGOQ8IU_h0vXUbeRUnZqCgoDg_D6wL839jgyk6kUKYSiucZORztRHPy4-WtrO1WG22JbiJeVBjqZeTNbjmejCVqTVhu0h5RofdTIUHPe9XYkRTb3MehyBnRI6UZ0TxeaRaXqdl3bJ8jTH7wP5j0ktwvk7orVhSHZH_dbsIr9KnW7nWylD-o5BvH
  priority: 102
  providerName: Scholars Portal
Title Hsa_circ_0046264 up-regulated BRCA2 to suppress lung cancer through targeting hsa-miR-1245
URI https://www.ncbi.nlm.nih.gov/pubmed/29891014
https://www.proquest.com/docview/2056638666
https://search.proquest.com/docview/2054918597
https://pubmed.ncbi.nlm.nih.gov/PMC5996480
https://doaj.org/article/42acb0f5f9204a0eb0585bc56688532b
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtB2MvY9_z1gUNBoOBGtnW52MSWsIgpYQVwl6EpMhroHFCPv7_nWQ71OxtL36wJJB0v_Pd-b4Q-sasskFXnMjSKsI8p8TyYIl1UvNy6UHmRY_u7FZM79nPBV-cId7lwqSgfe9WV_Xj-qpePaTYyu3aD7s4seHdbBJLijBFh-foHADameit6wAQyJuUIk60LvLWlZkrMdxH4Rat51iUOdckduCLFchjv9qeXErl-__9SD-RUv0Iyici6eYVetnqknjU7Pk1Ogv1G_R81nrL36Lf0701frXzJiWHCoaPW7Jrms-HJR7PJ6MCHzZ4f9ymcFj8CJyPfcTBDrcNfHATKg4CDj_sLVmv5gRkNX-H7m-uf02mpO2lQDzoNAeigrJwI9SWoEJQ6WmQlXNSLYvcMymDtjZUviptFUCAM2atL5UtrFWKK-fy8j26qDd1-IiwBsZ1ITAnKGNyqVTMhhVMCF_mpQzLDP3obtJsm5IZJpkaSpiGAgYoYCIFjMzQON71aWKsdp1ebHZ_TEtzwwrrHa14pQvKLA2OgpHj4GACdlcWLkPfI6VM5Ekgh7dtagHsN1a3MiPOhNJMlDRDl72ZwEu-P9zR2rS8vDcF6IjwlQI7L0NfT8NxZYxPq8PmmOYwDaqPhgN9aKBxOlKHsAzJHmh6Z-6PAPBTpe8W6J_-e-Vn9KJIcBckzy_RxWF3DF9Aizq4AfDOQg7Qs_H17d18kP5FwHPG1CDx01_xpxsu
link.rule.ids 230,315,730,783,787,867,888,2109,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dixMxEA96B-qL-O3qqREEQQhmN5_7JO1xR9VrkXIHxZeQZLNeQdu62_7_TnbTeovga5NCMpnJb2Zn8huE3nGrbShrQRSzmnAvKLEiWGKdKgWrPGBezOhOZ3Jyxb8sxCJ9cGtTWeX-Tuwu6mrt4zdyCNLB8WAavO1Pm98kdo2K2dXUQuM2Oo5UVRB8HY_PZt_mhzwCqKPo3xcJAki8SHnNXMuPbUS6GEpHhua8JGqATB2B_7_X9A2cGtZQ3gCl8wfofvIm8ag__ofoVlg9QnemKV_-GH2ftNb4ZeNN9zxUcrzbkKZvPx8qPJ6fjgq8XeN2t-kKYvFPsH3soyY0OLXwwX2xOEAcvm4t-bWcE0Br8QRdnZ9dnk5I6qZAPHg1W6KDtiAGahk4EVR5GlTtnNJVkXuuVCitDbWvma0DQDjn1nqmbWGt1kI7l7On6Gi1XoXnCJdgui4E7iTlXFVax_ewkkvpWc5UqDL0YS9Js-lJM0wXbGhperEbELuJYjcqQ-Mo68PEyHfd_bBufphkPoYX1jtai7osKLc0OAphjoONSVgdK1yG3seTMtEq4Ti8TY8LYL2R38qMBJe65JLRDJ0MZoI1-eHw_qxNsubW_NW9DL09DMd_xgq1VVjvujm8BOenhA0961XjsKXIch97ImdIDZRmsOfhyGp53XF9R_YcrumL_y_rDbo7uZxemIvPs68v0b2iU2pJ8vwEHW2bXXgFjtPWvU7W8QdVABJf
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZaxsxEBZtCqEvJb23SVsVCoWCYu2uzkfHrXEPhxAaCH0RklbbGOK18fH_O9KujZe-9XUlgUbzzc4McyH0kVllg645kaVVhHlOieXBEuuk5mXlQefFiO70Ukxu2Pdbfnsw6isl7Xs3O2_u5-fN7C7lVi7nfrDLExtcTUexpQhTdLCs6sFD9Ahkloqdo94FEACHvC0s4kTrIu8CmrkSg3VUcdGHjq2Zc03iHL7YhzxOre1pp9TE_99f9YGu6udRHiim8Ql60lmUeNje_Cl6EJpn6Hjaxcyfo9-TtTV-tvImlYgKhrdLsmpH0IcKX1yPhgXeLPB6u0xJsfge5B_7iIYV7sb44DZhHNQcvltbMp9dE9DY_AW6GX_9NZqQbqIC8WDZbIgKysKLUFuCIUGlp0HWzklVFblnUgZtbah9Xdo6gBpnzFpfKltYqxRXzuXlS3TULJrwGmEN4utCYE5QxmSlVKyJFUwIX-alDFWGPu9e0izbxhkmORxKmJYDBjhgIgeMzNBFfOv9xtjzOn1YrP6YjvOGFdY7WvNaF5RZGhwFV8cBYQJuVxYuQ58ip0yUTGCHt12BAdw39rgyQ86E0kyUNENnvZ0gUb6_vOO16SR6bQqwFOFfBd5ehj7sl-PJmKXWhMU27WEaDCANBL1qobEnaYewDMkeaHo091cA_qnfdwf3N_998j06vvoyNj-_Xf44RY-LhHxB8vwMHW1W2_AWzKqNe5cE6C9dWBtH
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hsa_circ_0046264+up-regulated+BRCA2+to+suppress+lung+cancer+through+targeting+hsa-miR-1245&rft.jtitle=Respiratory+research&rft.au=Liu+Yang&rft.au=Jun+Wang&rft.au=Yaodong+Fan&rft.au=Kun+Yu&rft.date=2018-06-11&rft.pub=BMC&rft.eissn=1465-993X&rft.volume=19&rft.issue=1&rft.spage=1&rft.epage=13&rft_id=info:doi/10.1186%2Fs12931-018-0819-7&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_42acb0f5f9204a0eb0585bc56688532b
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon